Unfortunately its not accessible to in patients that we have in our local hospitals as well as our jails. I would also note that our city purchases many of our drugs for our inpatient populations and others with a contract through a Company Called innovation. Unfortunately the pricing for those particular drugs are covered by nondisclosure agreement and we dont have the ability to understand how those prices are set. The resolution is asking for four things. It asks the department of Public Health to use consumer websites to provide comparisons for drugs in San Francisco and asks for the drug pricing through all inpatient settings federal legislative agenda for this year. We also state that the board of supervisors will increase transparency in pricing for health care and prescription drugs and also a firms our city supports for pharmaceutical prices and rate setting process. I want to take a moment to thank all the advocacy organizations and our residents that have been disproportiona
The city and county of San Francisco. Some of the out patients are eligible to receive a low price negotiated by the federal government in the socalled 340 b program. Unfortunately its not accessible to in patients that we have in our local hospitals as well as our jails. I would also note that our city purchases many of our drugs for our inpatient populations and others with a contract through a Company Called innovation. Unfortunately the pricing for those particular drugs are covered by nondisclosure agreement and we dont have the ability to understand how those prices are set. The resolution is asking for four things. It asks the department of Public Health to use consumer websites to provide comparisons for drugs in San Francisco and asks for the drug pricing through all inpatient settings federal legislative agenda for this year. We also state that the board of supervisors will increase transparency in pricing for health care and prescription drugs and also a firms our city suppo
Again. In addition cmd implemented a web base monitoring tool to help track lbe compliance. For our follow ups, our office we use a risk base approach to select specific recommendations that the departments report for field testing. This is where we actually go out to the office and we go in to test. We gather evidence to determine if the departments implementation resolved the problem underlying the recommendation and issue a memo reporting our findings. Our follow up go through the same process as the report. We company a follow up at 6 months, 1 year and 2 years. This time we actually go out into field and again do a testation work. During the First Quarter of this year we had one follow up of process and sf puc management with lease with aggregate which leases a rock query. What we found was that puc has significant weaknesses in its oversight and owed the city more than 64,000. The greater detail will be provided in our report for the fiscal year. We did find that the 11 recommend
As well as our jails. I would also note that our city purchases many of our drugs for our inpatient populations and others with a contract through a Company Called innovation. Unfortunately the pricing for those particular drugs are covered by nondisclosure agreement and we dont have the ability to understand how those prices are set. The resolution is asking for four things. It asks the department of Public Health to use consumer websites to provide comparisons for drugs in San Francisco and asks for the drug pricing through all inpatient settings federal legislative agenda for this year. We also state that the board of supervisors will increase transparency in pricing for health care and prescription drugs and also a firms our city supports for pharmaceutical prices and rate setting process. I want to take a moment to thank all the advocacy organizations and our residents that have been disproportionately affected by the rising cost. Starting with the leadership and the disability ac
Going to our schools and making our neighborhood safe. But unfortunately even our residents that have good coverage are spending this money on medications. There are a lot of complicated issues that under lie why drug pricing is so high. There are a couple things that i would like to note that i have certainly explored with city staff on this issue. We have very little transparency on the prices set not only with drugs but also prices paid by the city and county of San Francisco. Some of the out patients are eligible to receive a low price negotiated by the federal government in the socalled 340 b program. Unfortunately its not accessible to in patients that we have in our local hospitals as well as our jails. I would also note that our city purchases many of our drugs for our inpatient populations and others with a contract through a Company Called innovation. Unfortunately the pricing for those particular drugs are covered by nondisclosure agreement and we dont have the ability to un